FDA Investigator Yvins Dezan

Yvins Dezan has conducted inspections on 87 sites in 12 countries as of 14 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
14 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Canada, Germany, Korea (Republic of), China, Trinidad and Tobago, Netherlands, Austria, Argentina, Bahamas, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Yvins Dezan:
Aaron J Adler, Addam S Reynolds, Ademola O Daramola, Adetutu M Gidado, Alan L Truong, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Amber D Brodas, Amy L Singer, Amy M Codella, Amy M Cramer, Angela E Glenn, Angele C Smith, Ankur C Patel, Annemarie Bodnar, Annet R Rajan, Anney Lin, Anthony C Warchut, Antonina Aydanian, Ariel Cruz Figueroa, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashar P Parikh, Asia D Clark, Atul J Agrawal, Barbara A Gullick, Barbara J Maulfair, Barbara Jwilimczyk Macri, Barbara M Frazier, Bijoy Panicker, Binh T Nguyen, Bonita S Chester, Brandon C Heitmeier, Brett R Havranek, Brian D Nicholson, Brian S Keefer, Brooke K Higgins, Bryan A Galvez, Bryan L Mcguckin, Burnell M Henry, Cara M Minelli, Carla J Lundi, Carrie A Hughes, Cary Greene, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Chaltu Nwakijra, Charles D Brown, Charles I Ann, Charles J Chacko, Charles Jewell, Charles L Larson, Charles R Cote, RIC, Charlotte E Wilkins, Cheryl D Mccall, Chiang Syin, PhD, Christina K Theodorou, Christopher W Buser, Comyar Shoghi, Concepcion Cruz, Jr, Constance Y Fears, Craig D Zagata, Crystal Monroy, Cynthia Jim, CSO, Dale A Nyberg, Daniel J Grabicki, Daniel J Roberts, Daniel T Lee, Darren S Brown, David A Oluwo, David J Gomes, David J Hafner, Debra J Bennett, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Digiulio, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Dhaval H Patel, Diane C Thibodeau, Diane Cvan Leeuwen, Diane Goll, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Douglas W Gronski, Dr. Dominick Roselle, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. S Nar Ali, PhD, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward D Mcdonald, Edwin Melendez, Eileen A Liu, Emest F Bizjak, Emily A Baldwin, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Erika V Butler, Erin D Mccaffery, Esther C Broner, PhD, Farhana Khan, Felix Maldonado, Frank J Marciniak, Fred Razzaghi, Freddy Ortiz Colon, Frederick F Razzaghi, Freyja V Lynn, Gayle S Lawson, Gene R Gunn, George Pyramides, Gianine E Tompkins, Guerlain Ulysse, Guo Q Shen, Gwyn G Dickinson, Haitao Li, Hector Jcolon Torres, Heidy C Perales, Helen B Ricalde, Helen Verdel, Hyojong Kwon, PhD, Israel Santiago, OCM, Ivis L Negron, Ivy E Sweeney, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jai P Singh, James C Maclaughlin, James M Mason, James M Simpson, James Norman, James R Birkenstamm, Janet A Rajan, Javier O Vega, Jawaid Hamid, Jay B Shah, Jeffrey P Raimondi, Jennifer L Bridgewater, Jennifer L Gustavus, Jennifer L Huntington, Jennifer M Gogley, Jessica S Estriplet, Joey V Quitania, Jogy George, John A Gonzalez, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose Martinez, Jr, Jose Ohernandez Guzman, Jose Velez, Joseph W Matthews, Joy Rkozlowski Klena, Juanita P Versace, June P Page, Junho Pak, Justine Tomasso, Karen E D'orazio, Karen L Kosar, Katherine Szestypalow, Kathleen M Jordan, Keith M Reilly, Kejun Cheng, Kelli F Dobilas, Kellia N Hicks, Kelvin X Sanders, Kenneth H Williams, Kenneth M Gordon, Kenneth Nieves, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Kimberly M White, Ko U Min, Krishnaiah Yellela, Kristina J Donohue, Kristina L Conroy, Kristy A Zielny, Kumar G Janoria, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Laurimer Kuilan Torres, Lawrence Harmon, Jr, LCDR Susan E Polifko, Li Hongpaul Yeh, PhD, Li Li, Liatte Kreuger, PharmD, Lillian S Wu, Liming Zhang, Linda L Green, Linda R Kuchenthal, Linda Thai, Lindsey M Schwierjohann, Lisa M Bellows, Loretta Nemchik, Lori M Newman, Lori Peters, Lori S Lawless, LT Richard A Lyght, Lucas B Leake, Luis A Dasta, Makini Cobourne Duval, PhD, Marc S Neubauer, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcus A Ray, Margaret M Annes, Margaret M Doherty, Maria C Agpaoa, Maria C Fermin, Maria Estrella, Maria Joselopez Barragan, PhD, Maria Manzoni, PhD, Maria Pkelly Doggett, MBA, Marie F Morin, Marjorie A Shapiro, PhD, Mark R Mcclain, Marsha W Major, Marshalette O Edwards, Martha T Olone, Marvin D Jones, Mary Davis Lopez, Massoud Motamed, Mate Tolnay, Matthew A Spataro, Matthew B Casale, Matthew M Henciak, Maya M Davis, Mayar M Mussa, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Michael A Taylor, Michael D Garcia, Michael L Casner, Michael L Chasey, Michael R Goga, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michael T Cyrus, Miguel A Martinez Perez, Mihaly S Ligmond, Milan S Blake, Monika Borkowska, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Myra K Casey, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nancy T Waites, Nayan J Patel, Neal L Adams, Nealie C Newberger, Nebil A Oumer, Nicholas A Violand, Nicholas L Paulin, Nicole E Knowlton, Nije A Thomas, Niketa Patel, Noreen Muñiz, Omotunde O Osunsanmi, Pal S Mayasandra, Pankaj H Amin, Parul M Patel, Patrice S Hall, Patrick C Klotzbuecher, Patrick L Wisor, Paul L Bellamy, Paul Mouris, Paul R Whitby, Paula A Trost, Pearl C Ozuruigbo, Perry T Nichols, Peter E Baker, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Rachael L Cook, Rachael O Oyewole, Rachel C Harrington, Rajiv R Srivastava, Raymond L Cheung, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard L Rutherford, Richard W Thornton, Rita K Kabaso, Robert C Coleman, Robert H Wittorf, Robert J Martin, Robert Jennings, Robin P Mathew, Rochelle L Cross, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Samina S Khan, Sandra A Hughes, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah B Tanksley, Satheesh Thomas, Scott E Norris, Scott T Ballard, Sean R Marcsisin, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Shirshendu K Deb, PhD, Simone E Pitts, Sinai I Davis, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Stephen D Brown, Stephen J Mottola, Stephenie M Ortiz, Steven M Weinman, Sundy V Sedwick, Susan F Laska, MS, Susan M Halsted, Susan M Jackson, Susanna E Ford, Susanne M Richardson, MS RAC, Suzanne M Healy, Syed N Ali, Taichun Qin, PhD, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Tarun D Mehta, Ted L Anderson, Teresa I Navas, Thomas E Friel, Tiara Nbrown Crosen, Tiffani D Wilson, Timothy T Kapsala, Tina S Roecklein, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie L Whipp, Veronica Fuentes, MS, Victoria Spivak, Virgilio F Pacio, CSO, Viviana Matta, Vivin George, Vlada Matusovsky, Walter L Fava, Wanda Y Honeyblue, Wayne E Seifert, William A Warnick, William J Leonard, William R Chang, Xiaohan Cai, PhD, Yasamin Ameri, Yiyue Zhang (nmi), PhD, Youmin Wang, Young M Choi, PhD, Yumi J Hiramine, Yvesna C Blaise, Zachary A Bogorad, Zachary L Miller, Zakaria I Ganiyu, Zedong Dong, Zhong Li, PhD, Zhongren Wu

Yvins Dezan's Documents

Publish Date Document Type Title
March, 2018 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2018-03-09
January, 2022 EIR Sharp Packaging Services, LLC - EIR, 2022-01-28
January, 2023 FDA 483 Megafine Pharma (P) Limited - Form 483, 2023-01-24
August, 2019 FDA 483 Laxai Life Sciences Private Limited - Form 483, 2019-08-03
April, 2022 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2022-04-13
August, 2018 FDA 483 LOBA biotech Gmbh - Form 483, 2018-08-17
February, 2018 EIR Cosette Pharmaceuticals, Inc. - EIR, 2018-04-10
October, 2020 FDA 483 Pharmaceutics International, Inc. - Form 483, 2020-10-30
July, 2017 FDA 483 LTS Lohmann Therapy Systems Corp. - Form 483, 2017-07-13
October, 2018 FDA 483 Centurion Laboratories Private Limited - Form 483, 2018-10-26
October, 2020 EIR Pharmaceutics International, Inc. - EIR, 2020-10-30
March, 2023 FDA 483 LUPIN LIMITED - Form 483, 2023-03-29
February, 2018 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2018-02-15
January, 2017 EIR W.Y. Industries, Inc. - EIR, 2017-01-05
August, 2022 FDA 483 Jubilant Generics Limited - Form 483, 2022-08-01
October, 2020 FDA 483 Pharmaceutics International, Inc. - Form 483, 2020-10-30
March, 2022 FDA 483 Elvi Pharma LLC. - Form 483, 2022-03-25
January, 2017 FDA 483 Products Africana, Inc. - Form 483, 2017-01-26
March, 2024 FDA 483 Alkem Laboratories Limited - Form 483, 2024-03-27
September, 2022 FDA 483 CTX Lifesciences Pvt. Ltd. - Form 483, 2022-09-02
June, 2019 EIR Maprimed S.A. - EIR, 2019-06-07
June, 2019 FDA 483 Response Maprimed S.A. - Form 483R, 2019-06-28
September, 2020 EIR BIOCON GENERICS INC - EIR, 2020-09-08
February, 2023 FDA 483 Strides Pharma Science Limited - Form 483, 2023-02-24
May, 2019 FDA 483 Coral Pharmaceuticals LTD - Form 483, 2019-05-24
January, 2022 FDA 483 Sharp Packaging Services, LLC - Form 483, 2022-01-28
May, 2018 FDA 483 Actavis LLC - Form 483, 2018-05-07
December, 2023 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2023-12-11
March, 2020 FDA 483 Progenics Pharmaceuticals, Inc. - Form 483, 2020-03-20
October, 2017 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2017-10-25
August, 2019 FDA 483 NATCO PHARMA LIMITED - Form 483, 2019-08-09
August, 2022 FDA 483 Jubilant Generics Limited - Form 483, 2022-08-01
August, 2018 FDA 483 Excella GmbH & Co. KG - Form 483, 2018-08-10
December, 2017 FDA 483 Reliance Life Sciences Private Limited - Form 483, 2017-12-13
January, 2019 FDA 483 LUPIN LIMITED - Form 483, 2019-01-25
September, 2021 FDA 483 Ecometics, Inc. - Form 483, 2021-09-10
November, 2021 FDA 483 Alembic Pharmaceuticals Limited - Form 483, 2021-11-10
September, 2020 FDA 483 BIOCON GENERICS INC - Form 483, 2020-09-08
October, 2019 FDA 483 Taejoon Pharmaceutical Co., Ltd. - Form 483, 2019-10-15
May, 2019 FDA 483 CGA Limited - Form 483, 2019-05-31
July, 2023 FDA 483 Teva API India Private Ltd. - Form 483, 2023-07-18
October, 2019 FDA 483 SamChunDang Pharm Co, Ltd - Form 483, 2019-10-25
October, 2021 FDA 483 BIOLOGICAL E. LIMITED - Form 483, 2021-10-08
May, 2023 FDA 483 OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVATE LIMITED - Form 483, 2023-05-04
July, 2019 FDA 483 SHILPA PHARMA LIFESCIENCES LIMITED - Form 483, 2019-07-26
August, 2017 FDA 483 MFCI (Huanggang) Co., Ltd. - Form 483, 2017-08-17
March, 2018 FDA 483 Tianish Laboratories Private Limited - Form 483, 2018-04-09
February, 2019 FDA 483 Strides Pharma Science Limited - Form 483, 2019-02-05
June, 2018 FDA 483 Curium Netherlands B.V. - Form 483, 2018-06-01
October, 2020 EIR Pharmaceutics International, Inc. - EIR, 2020-10-30
June, 2021 FDA 483 Tris Pharma Inc - Form 483, 2021-06-08
March, 2018 FDA 483 Hetero Drugs Limited - Form 483, 2018-03-02
June, 2022 FDA 483 ARx, LLC - Form 483, 2022-06-03
January, 2022 FDA 483 Response Sharp Packaging Services, LLC - Form 483R, 2022-02-17
December, 2022 FDA 483 Jubilant Pharmova Limited - Form 483, 2022-12-13
October, 2020 EIR Sannova Analytical LLC - EIR, 2020-10-07
June, 2016 FDA 483 Nutra-Med Packaging - Form 483, 2016-06-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more